⌘K

Home/Filings/4/0001457612-22-000060

4//SEC Filing

Duvall Diantha 4

Accession 0001457612-22-000060

CIK 0001457612other

View on SEC.gov Company Profile

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:11 PM ET

Size

4.8 KB

Accession

0001457612-22-000060

Insider Transaction Report

Form 4

Period: 2022-05-26

GENOCEA BIOSCIENCES, INC.GNCA

CHIEF FINANCIAL OFFICER

Transactions

Sale
Common Stock
2022-05-26$0.08/sh−24,407$1,867→ 76,743 total

Footnotes (1)

[F1]Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.0765 to $0.0766, inclusive.

Documents

1 file

4
wf-form4_165359588823596.xmlPrimary
FORM 4

Issuer

GENOCEA BIOSCIENCES, INC.

CIK 0001457612

Entity typeother

Related Parties

1

filerCIK 0001696784

Filing Metadata

Form type: 4
Filed: May 25, 8:00 PM ET
Accepted: May 26, 4:11 PM ET
Size: 4.8 KB

View on SEC.gov